Suzhou Fushilai Pharmaceutical Co., Ltd. (SZSE: 301258)
Health Care · Pharmaceuticals · CN
CN¥27.40
+2.20% today · -18.5% 1Y
Suzhou Fushilai Pharmaceutical Co., Ltd. (SZSE: 301258) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $361.87M.
Over the last twelve months the share price has lost 18.5%, trading between 21.78 and 38.31.
Tweenvest scores Suzhou Fushilai Pharmaceutical Co., Ltd. across four factors: quality 69/100, value 44/100, growth 1/100, dividend 55/100. Its strongest factor is quality.
301258 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $361.87M
- Revenue (TTM)
- $58.05M
- P/E
- —
- EPS
- 0.07
- Dividend yield
- 0.80%
- Beta (5Y)
- 0.38
- 52-week high
- CN¥38.31
- 52-week low
- CN¥21.78
- Avg volume (3M)
- —
- Shares outstanding
- 88.59M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| JCR Pharmaceuticals Co., Ltd.TSE: 4552 | $371.13M | ¥481.00 | -1.84% |
| ASKA Pharmaceutical Holdings Co.,Ltd.TSE: 4886 | $365.48M | ¥2,030.00 | -5.89% |
| Honz Pharmaceutical Co., Ltd.SZSE: 300086 | $364.35M | CN¥5.37 | -14.35% |
| Deva Holding A.S.IBSE: DEVA | $362.23M | TL89.00 | -8.95% |
| GlaxoSmithKline Pakistan LimitedKASE: GLAXO | $361.36M | PKRs314.59 | +0.03% |
| Qinghai Spring Medicinal Resources Technology Co., Ltd.SHSE: 600381 | $358.37M | CN¥4.20 | +7.97% |
| Solara Active Pharma Sciences LimitedNSEI: SOLARA | $358.23M | Rs714.85 | -3.29% |
| Ind-Swift Laboratories LimitedNSEI: INDSWFTLAB | $356.90M | Rs395.15 | -2.28% |
Figures last refreshed Oct 4, 2026.